Industry reports
Editor highlights

Outsourcing in Drug Development: The Contract CRO, Clinical Trial Lab and EDC Market

Kalorama Information
  • Publication date: January 2012
  • Report price: $ 3 995

Get this report today!

$ 3 995 - 1 User License
$ 5 995 - Department License
$ 7 990 - Corporate License

Summary

Table of Contents

The cost and time of developing and bringing a drug to market is over $1.3 billion and often takes as long as 15 years, if not longer. Because of this, major pharmaceutical marketers continue to outsource stages of development, and over the years Kalorama Information has observed this process. In past editions of our outsourcing market studies, we found that outsourcing moved from "should" to "must." for manufacturers. This trend has only continued in the past two years.


Contract Research Organizations (CROs) and other entities can expect growing demand for their services. The demand for new drugs remains unabated, but the cost and need to bring those drugs to market is ever-increasing and intensifying. A key cost driver is the large number of failures during the expensive clinical trial phases. Driven by pressures to reduce costs, companies are increasingly implementing outsourcing strategies to increase revenues through faster drug development. By decreasing their in-house facilities and staff, and outsourcing more of their R&D functions, pharmaceutical and biotechnology companies are reshaping the drug development services industry.


Kalorama Information's Outsourcing in Drug Development: The Contract Research (Clinical Trial) Market is the third edition of this study of the drivers for outsourcing drug development, the companies involved in this market and the opportunity for revenues.

As part of its comprehensive coverage of this market, this report contains:



  • A Detailed Introduction to the Clinical Trial Process

  • Statistics of Drugs in Development by Phase

  • Market Size and Forecasts for Outsourcing In Drug Development by Academic Medical Center (AMC), Contract Research Organizations and Others.

  • Main Drivers for Outsourcing in Drug Development

  • How CROs are Meeting the Challenge of Patient Recruitment

  • Discussion of Industry and Regulatory TrendsProtocols Funded in FY2009 by Percent and Gender

  • Global R&D Expenditures Outsourced by Percent 2003-2010

  • Selected Pharmaceutical Company Acquisitions, 2009-2011

  • Top Ten Therapeutic Categories in R&D

  • Selected Acquisitions of Leading CROs

  • Increasing role of EDCs

  • Globalization Trends in Drug Development and Breakout of Clinical Trials by Region

  • Directory of Companies

  • Market Share of Major CROs 2011

  • Profiles of CROs, Contract Laboratories, Clinical Trial Labs and EDC Solution Companies


Kalorama Information
  • Publication date: January 2012
  • Report price: $ 3 995

Get this report today!

$ 3 995 - 1 User License
$ 5 995 - Department License
$ 7 990 - Corporate License

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Global Drug Discovery And Development Industry : Latest Reports

Life Sciences BPO Market [Contract Research Organizations (Drug Discovery, Pre-Clinical, Clinical Trials, Medical Writing, Pharmacovigilance, Risk-Based Monitoring, Clinical Data Management, Biostatistics)and Contract Manufacturing Organizations] - Global

Life Sciences BPO Market [Contract Research Organizations (Drug Discovery, Pre-Clinical, Clinical Trials, Medical Writing, Pharmacovigilance, Risk-Based Monitoring, Clinical Data Management, Biostatistics)and Contract Manufacturing Organizations] - Global

  • $ 5 795
  • Industry report
  • February 2014
  • by Transparency Market Research

Life Sciences BPO Market [Contract Research Organizations (Drug Discovery, Pre-Clinical, Clinical Trials, Medical Writing, Pharmacovigilance, Risk-Based Monitoring, Clinical Data Management, Biostatistics)and ...

Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech

Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech

  • $ 5 495
  • Industry report
  • March 2014
  • by Currentpartnering

The Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the discovery, preclinical and ...

Biopreservation Market (Product Types - Equipment, LIMS, and Media; Applications - Regenerative Medicine, Biobanking, and Drug Discovery) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Biopreservation Market (Product Types - Equipment, LIMS, and Media; Applications - Regenerative Medicine, Biobanking, and Drug Discovery) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • $ 4 795
  • Industry report
  • February 2014
  • by Transparency Market Research

This report encompasses market estimations for biopreservation market for the forecast period 2013 to 2019. The market size is forecasted considering 2012 as the base year and is represented in terms of ...


Global Drug Discovery And Development Industry : Latest Downloads

Global Clinical Trial : Innovation and Technology Trends

  • Industry report
  • April 2014
  • 16 pages

... Complexities, and so on). Within the cro market, the largest segment was that of drug discovery. Based on various analyses, the report also anticipates that the market for clinical data management services ...

Drug Discovery and Development Industry Brief

  • Industry report
  • March 2014
  • 47 pages
  • by Research Paper

... Learn/confirm and predict phase vi registering and labeling (maa) uncertainty confident and drug and disease paediatric strategy & investigation plan scientific advice clinical trial ...

Clinical Trial : Innovation and Technology Trends

  • Industry report
  • December 2013
  • 22 pages

... Company. The transaction positions telerx for further expansion of one of its key vertical businesses 8 nov 12 smo n/a augment number of clinical trial sites to 57. Increase access to patients, conduct ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.